EAGLE PHARMACEUTICALS INC (EGRX): Institutional Ownership
Hedge funds and institutional managers reporting a position in EGRX · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
5
13F filers
Aggregate Value
$15.9M
Across holders
Last Price
$0.67
2026-06-26
Sector
Health Care
GICS
Holder activity5 new0 added0 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. CIK 0001165408 | Hedge Fund | 500K | $7.9M | 49.5% | 0.0% | New | — | Q3 2023 |
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 122K | $6.2M | 38.9% | 0.0% | New | — | Q4 2021 |
| AQR CAPITAL MANAGEMENT LLC CIK 0001167557 | Hedge Fund | 375K | $1.4M | 8.8% | 0.0% | New | — | Q3 2024 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 119K | $445K | 2.8% | 0.0% | New | — | Q3 2024 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 900 | $3K | 0.0% | 0.0% | New | — | Q3 2024 |
New
Hedge Fund
$7.9M· 49.5% of total· 0.0% port· 500K sh· — QoQ· Q3 2023
New
Hedge Fund
$6.2M· 38.9% of total· 0.0% port· 122K sh· — QoQ· Q4 2021
New
Hedge Fund
$1.4M· 8.8% of total· 0.0% port· 375K sh· — QoQ· Q3 2024
New
Hedge Fund
$445K· 2.8% of total· 0.0% port· 119K sh· — QoQ· Q3 2024
New
Hedge Fund
$3K· 0.0% of total· 0.0% port· 900 sh· — QoQ· Q3 2024